What does the FDA review mean for MOTS-c legal status?
FDA’s withdrawn-nominations record still lists safety concerns for MOTS-c. A clinician’s prescription and FDA drug approval are separate matters.
Has FDA approved MOTS-c as a drug?
MOTS-c began with a study of how cells turn food into energy. That work didn’t create an approved medicine. FDA hasn’t approved MOTS-c as a drug. Sellers mark MOTS-c for laboratory tests, not for treating you. The advisory meeting has taken place; its agenda records the subjects listed for discussion [18]. An advisory meeting cannot itself approve a drug or authorize pharmacy use.
What do FDA records say about MOTS-c today?
MOTS-c is a 16-amino-acid protein, meaning it is made from linked parts. Its DNA directions sit where a cell gets its energy. FDA hasn’t approved MOTS-c as a drug [16]. Federal law lets a pharmacy use a raw drug ingredient only in set cases. A standard drug guide accepted by federal law may support its use. FDA may also accept use in an approved drug or add the ingredient to its special pharmacy list [16]. A group of outside drug experts advises FDA about items that aren’t listed [16].
The FDA safety record lists MOTS-c among substances whose nominations were withdrawn. MOTS-c was previously in Category 2, and FDA still states safety concerns beside its entry. A withdrawn nomination is not a Category 1 placement or permission to compound. The meeting agenda documents an advisory discussion, not drug approval [18].
What step has MOTS-c reached in the FDA review?
MOTS-c has no FDA approval and is not on the 503A Bulks List [16]. Taking back a nomination does not remove FDA’s listed safety concerns. The meeting agenda records an advisory discussion; it is neither drug approval nor a list decision [18].
How do local pharmacies and large drug-making sites differ?
Two parts of federal law cover drugs prepared in a pharmacy [16]. One part covers a drug prepared for one patient by name. Your licensed doctor writes the prescription before a state-licensed pharmacy makes it. The other part covers registered facilities that prepare bigger batches, and FDA checks them under different rules [16].
A pharmacy may begin with the raw part that makes a medicine work only when federal rules allow it [16]. Legal support may come from a standard drug guide named in federal law, an approved medicine, or a special FDA list. An advisory discussion does not authorize an ingredient’s use, and approval of a finished drug is a separate question.
An advisory meeting alone does not authorize a pharmacy to use MOTS-c [16].
What does the FDA advisory meeting establish?
The FDA advisory agenda lists two forms of MOTS-c for discussion [18]. The same plan names BPC-157 and TB-500, which are other lab compounds. Their review doesn’t change what FDA must decide about MOTS-c [18].
The group can only advise FDA. It can’t add MOTS-c to the list or change the law [18]. FDA must make any final list through its own rule process. The experts may give advice, but they can’t decide for FDA [16]. The agenda identifies subjects for discussion. It does not report a final FDA list decision [18].
A prescription does not itself change federal compounding rules [16][17].
For you, the agenda is evidence of discussion; it grants no FDA approval.
What must happen before a pharmacy can make medicine for you?
A pharmacy may prepare medicine for a named patient once a licensed doctor has checked that person [17]. If the medicine fits the patient’s needs, the doctor writes a prescription. The local pharmacy may then prepare it, while a registered drug-making site follows other rules for bigger batches [17].
The doctor may check you by video [17]. That kind of visit doesn’t change which drugs a pharmacy may make. The doctor must truly be treating you and must write a valid prescription. Federal rules must also allow the drug’s active part. Neither a video visit nor a prescription exempts a pharmacy from federal compounding rules [16][17]. These facts explain the law; they don’t choose your care or offer you a drug.
Can a pharmacy make MOTS-c for you now?
A pharmacy can use only an ingredient allowed by federal rules. A licensed doctor treating you must also write your prescription [16][17]. MOTS-c prescription care has begun at Promise Peptides (mypromise.com), where a clinician licensed in the U.S. decides each person’s case. Requests can end without a prescription. Only U.S. patients are served, and the options differ with the patient’s state and the proposed treatment. The compounded MOTS-c medicine has no FDA approval. The advisory agenda alone grants no permission to compound [18].